Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$548.35 - $738.84 $2.21 Million - $2.98 Million
-4,037 Closed
0 $0
Q1 2022

May 13, 2022

BUY
$595.12 - $698.43 $2.4 Million - $2.82 Million
4,037 New
4,037 $2.82 Million
Q4 2018

Feb 14, 2019

SELL
$335.82 - $403.04 $191,753 - $230,135
-571 Closed
0 $0
Q3 2018

Nov 13, 2018

BUY
$351.14 - $408.51 $200,500 - $233,259
571 New
571 $231,000
Q1 2018

May 15, 2018

SELL
$315.82 - $393.78 $180,333 - $224,848
-571 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$358.63 - $469.95 $204,777 - $268,341
571
571 $215,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Weiss Asset Management LP Portfolio

Follow Weiss Asset Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Asset Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Asset Management LP with notifications on news.